Adam Suleman, MD^1,2, Amy Zhihui Zhu, PhD^3*, Anna Sinaiko, PhD^4*, Anca Prica, MD, MSc^2* and Danielle Rodin, MD, MPH^5*

¹Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
²Department of Medicine, University of Toronto, Toronto, ON, Canada
³University Health Network, Toronto, ON, Canada
⁴Department of Health Policy and Management, Harvard School of Public Health, Boston, MA
⁵Division of Radiation Oncology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada

David Fox^1*, Katherine L Rosettie^1*, Fadoua El Moustaid^1*, Anthony Masaquel^1*, Lourenia Cassoli^1* and Christopher R. Flowers, MD, MS²

¹Genentech, Inc., South San Francisco, CA
²MD Anderson Cancer Center, Houston, TX

Pallawi Torka, MD¹, Anthony Masaquel^2*, Lourenia Cassoli^2*, David Fox^2*, Arliene Mangalindan^2* and Ajay Major, MD, MBA³

¹Memorial Sloan Kettering, New York, NY
²Genentech, Inc., South San Francisco, CA
³University of Colorado School of Medicine, Aurora, CO

Matthew Matasar, MD, MS¹, Katherine L Rosettie^2*, Almut Mecke^3*, Danilo Di Maio^3*, Shih-Wen Lin^2*, Mei Wu^2* and Esprit Ma^2*

¹Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ
²Genentech, Inc., South San Francisco, CA
³F. Hoffmann-La Roche Ltd, Basel, Switzerland

Kristine A Karvonen, MD^1,2, Morgan A. Paul, MS^3*, Yael Flamand, MS^3*, Puja J. Umaretiya, MD, MS^4*, Rahela Aziz-Bose, MD^5,6,7, Colleen A. Kelly, MD^5,6, Leanne Duhaney, MD, MPH^8*, Daniel J. Zheng, MD⁹, Lucille Lokko, BA^5*, Victoria Koch, BS^10*, Peter D. Cole, MD¹¹, Lisa M. Gennarini, MD^12*, Justine M. Kahn, MD, MSc¹³, Kara M. Kelly, MD^14,15, Thai Hoa Tran, MD¹⁶, Bruno Michon, MD^17*, Jennifer J.G. Welch, MD¹⁸, Joanne Wolfe, MD, MPH^19*, Lewis B. Silverman, MD²⁰ and Kira Bona, MD, MPH^5,6,21

¹Seattle Children's Research Institute, Seattle, WA
²Department of Pediatric Hematology/Oncology, University of Washington, SEATTLE, WA
³Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁴Childrens Medical Center Dallas, UT Southwestern, Dallas, TX
⁵Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
⁶Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA
⁷Division of Population Sciences, Dana-Farber Cancer Institute, Jamaica Plain, MA
⁸Department of Cardiology, Boston Children's Hospital, Boston, MA
⁹Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
¹⁰Dana-Farber Cancer Institute, Boston, MA
¹¹Division of Pediatric Hematology/Oncology, Rutgers Cancer Institute, New Brunswick, NJ
¹²Division of Pediatric Hematology/Oncology and Blood & Marrow Cell Transplant, Montefiore Medical Center, Bronx, NY
¹³Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Columbia University Irving Medical Center, New York, NY
¹⁴Roswell Park Cancer Center, Buffalo, NY
¹⁵Division of Pediatric Hematology/Oncology, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY
¹⁶Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, CHU Sainte-Justine, Montreal, QC, Canada
¹⁷Centre Hospitalier de l'Universite Laval, Quebec City, QC, Canada
¹⁸Division of Pediatric Hematology and Oncology, Hasbro Children’s Hospital, Warren Alpert Medical School of Brown University, Providence, RI
¹⁹Departments of Pediatrics, Massachusetts General and Brigham and Women’s Hospitals, Boston, MA
²⁰Division of Pediatric Hematology/Oncology, Columbia University Irving Medical Center, New York, NY
²¹Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA

Ellen Zhang, MD, Natasha Steele, MD, MPH^*, Maya Ramachandran, MD^* and Ilana Yurkiewicz, MD

Stanford Health Care, Palo Alto, CA

Saurabh Dahiya, MD, FACP^1*, Ashley C. Saunders, MPH, MSc^2*, Jinender Kumar, MS^2*, William Ngantung, BS^3* and Matia Saeedian, PharmD, MS^3*

¹Stanford University School of Medicine, Stanford, CA
²Bristol Myers Squibb, Princeton, NJ
³BluePath Solutions, Los Angeles, CA

Kim Abbegail Tan Aldecoa, MD^1,2, Kah Poh Loh, MD, MBBCH BAO, MS³, Yi Lee, MD^4*, Noha Soror, MD, MSc⁵, Camelia Arsene, MD, PhD, MHS^1,2*, Geetha Krishnamoorthy, MD^1,2* and Meera Mohan, MD⁶

¹Department of Internal Medicine, Trinity Health Oakland, Pontiac, MI
²Wayne State University, Detroit, MI
³University of Rochester Medical Center, Rochester, NY
⁴Hematology and Oncology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
⁵Stephenson Cancer Center, University of Oklahoma Health Science Center, Oklahoma, OK
⁶Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI

Michael Slade, MD, MS¹, Ravi Vij, MD, MBA¹, Keith Stockerl-Goldstein, MD², Mark A. Schroeder, MD², Angela Vickroy, ANP^2*, Margaret Kavanaugh, ANP-BC^1*, Carmen Wilson, PA-C^1* and Mark Fiala, PhD^1*

¹Division of Oncology, Washington University School of Medicine, Saint Louis, MO
²Division of Oncology, Washington University School of Medicine, St. Louis, MO

Swetha Kambhampati, MD¹, Allison Dillon^2*, Paul Cockrum^3* and Syvart Dennen^4*

¹City of Hope National Medical Center, Yorba Linda, CA
²Genesis Research, Hoboken, NJ
³Ipsen Biopharmaceuticals, Inc., Cambridge, MA
⁴Genesis Research Group, Hoboken, NJ

Sameh Gaballa, MD¹, Mei Xue^2*, Todor I Totev^3*, Yan Meng, PhD^4*, Swetha Challagulla^2*, Zhuo Chen^3* and Keri Yang^2*

¹Moffitt Cancer Center, Tampa, FL
²BeiGene, San Mateo, CA
³Analysis Group, Inc., Boston, MA
⁴Analysis Group, Ltd, London, United Kingdom

Gloria Iacoboni, MD^1*, Pere Barba, MD¹, Irma Khvedelidze^2*, Maud Ngoya^2*, Paolo Corradini, MD³, Pierre Sesques, MD^4*, Marion Subklewe, MD⁵, Maria Gomes Da Silva^6*, Gilles Crochet^7*, Jarosław Dybko^8*, Izaskun Zeberio^9*, Alejandro Martín García-Sancho^10*, Tom van Meerten^11*, Maeve O'Reilly^12*, Bertram Glass, MD^13*, Ana Maria Sureda Balari, MD, PhD¹⁴, Peter Dreger¹⁵, Olivier Hermine, MD, PhD^16* and Ali Bazarbachi, MD, PhD¹⁷

¹University Hospital Vall d’Hebron, Barcelona, Spain
²EBMT Paris Study Unit, Paris, France
³Fondazione IRCCS Istituto Nazionale dei Tumori Milano, University of Milano, Milano, Italy
⁴CHU Lyon-Sud, Lyon, France
⁵Department of Medicine III, LMU University Hospital, Munich, Germany
⁶Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, PRT
⁷CHU UCL Namur, Yvoir, Belgium
⁸Department of Hematology and Cellular Transplantation, Lower Silesian Oncology Center, Wroclaw, Poland
⁹Hematology Department, Hospital Universitario Donostia, San Sebastian, ESP
¹⁰Hospital Universitario de Salamanca, IBSAL, CIBERONC, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain
¹¹Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
¹²Department of Hematology, University College London Hospitals, London, United Kingdom
¹³Department of Hematology and Stem Cell Transplantation, Helios Klinikum Berlin-Buch, Berlin, Germany
¹⁴Clinical Hematology Department, Institut Català d’Oncologia-Hospitalet, IDIBELL, Barcelona, Spain
¹⁵Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany
¹⁶INSERM U1163 Laboratory of cellular and molecular mechanisms of hematological disorders and therapeutic implications, Institut IMAGINE, Université Paris Cité, Paris, France
¹⁷American University of Beirut Dept. of Medicine, Beirut, Lebanon

Edward R Scheffer Cliff, MBBS, MPH^1,2, David A Russler-Germain, MD, PhD³ and Amar H. Kelkar, MD, MPH, FACP^4,5

¹Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
²Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
³Siteman Cancer Center, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
⁴Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA
⁵Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Sikander Ailawadhi, MD¹, Yelak Biru^2*, Solène Clavreul^3*, Maite San Miguel^4*, Nicolas Cormier^5*, Anna Sato^6*, Cathy Zeanah^6*, James Farrell^7*, Erinn Hoag Goldman⁸ and Rakesh Popat^9*

¹Division of Hematology-Oncology, Mayo Clinic-Florida, Jacksonville, FL
²International Myeloma Foundation, Greater Los Angeles, CA
³Myeloma Patients Europe, Brussels, Belgium
⁴Clínica Universidad de Navarra, Pamplona, Spain
⁵Centre Hospitalier Universitaire de Nantes, NANTES, FRA
⁶ZS Associates, New York, NY
⁷Pfizer Ltd, Dublin, Ireland
⁸Pfizer Inc, New York, NY
⁹National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Trust, London, GBR

Alex Y Ge, MD^1*, William B Feldman, MD, DPhil, MPH^2,3*, Martin F Kaiser, MD⁴, Kai Rejeski, MD^5,6, Gloria Iacoboni, MD^7*, Michael J Dickinson, MBBS, DMedSci, FRACP, FRCPA^8,9, Aaron S Kesselheim, MD, JD, MPH^3* and Edward R Scheffer Cliff, MBBS, MPH^8,10,11

¹Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA
²Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
³Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
⁴The Institute of Cancer Research, London, ENG, United Kingdom
⁵Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany
⁷Department of Hematology, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Universitat Autònoma of Barcelona (UAB), Barcelona, Spain
⁸Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
⁹Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia
¹⁰Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
¹¹Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia

Xinjie Jonathan Tang, MBBS¹, Joanne Shu Xian Lee^2*, Esther Hian Li Chan^1,3*, Sanjay De Mel, BSc, FRCPath, MRCP^4*, Yen-Lin Chee^2,3*, Wee-Joo Chng^3,4,5, Nicole-Ann Lim^6*, Jason Yongsheng Chan⁶, Soon Thye Lim^6*, Shi Hui Clarice Choong^1,3*, Melissa Gaik-Ming Ooi^1,3* and Michelle Limei Poon^1,3*

¹Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore
²Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
³Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
⁴Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore
⁵Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
⁶Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore

Christopher T. Su, MD, MPH^1,2, Rahul Banerjee, MD, FACP^1,2, Li Li, MA MPA^1*, Catherine Fedorenko, MMSc^1*, Andrew J. Cowan, MD^1,2, Scott D. Ramsey, MD PhD^1,2* and Veena Shankaran, MD MS^1,2*

¹Fred Hutchinson Cancer Center, Seattle, WA
²University of Washington, Seattle, WA

Tariqa Ackbarali, MSc^1*, Danielle M. Brander, MD² and Matthew S. Davids, MD, MMSc³

¹PlatformQ Health, Lake Worth, FL
²Duke University, Durham, NC
³Department of Medical Oncology, Dana-Farber Cancer Institute, Inc., Boston, MA

Brian Hoeynck, MD¹, Shakthi Bhaskar, MD², Andrew P Jallouk, MD, PhD³, Bhagirathbhai R. Dholaria, MBBS¹, Bipin N. Savani, MD², Olalekan O. Oluwole, MD, MPH, MBBS², David Morgan, MD^2*, Salyka M. Sengsayadeth, MD^2*, Adetola A. Kassim, MD, MBBS, MS¹ and Vivek Patel, MD²

¹Vanderbilt University Medical Center, Nashville, TN
²Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
³The University of Texas MD Anderson Cancer Center, Nashville, TN

Anneleen Vanhellemont, MSc, RN^1*, Annemarie Coolbrandt, MSc, RN^1*, Evi Vandeneede, MSc, RN^1*, Gwen Aerts, MSc^2*, Lise Lynen, MSc^2*, Yoline Soeffers, MSc^3*, Annouschka Laenen, MSc^4*, Peter Vandenberghe, MD, PhD^5,6 and Michel Delforge^5,7*

¹Leuven, University Hospital, Leuven, Belgium
²Byteflies, Antwerpen, Belgium
³University Leuven, Leuven, Belgium
⁴Leuven Biostatistics and Bio informatics Centre, University Leuven, Leuven, Belgium
⁵University Hospital Gasthuisberg, Leuven, Belgium
⁶Department of Hematology, Department of Human Genetics, University Hospitals Leuven, KU Leuven, Leuven, Belgium
⁷University Hospital Leuven, Leuven, Belgium

Morie A. Gertz, MD¹, Heather J. Landau, MD², Vaishali Sanchorawala³, Manisha Bhutani, MD⁴, Jeffrey A. Zonder, MD ⁵, Michael Rosenzweig, MD⁶, Gray Magee, MD⁷, Cynthia Campos, MPH^8*, Irina Yermilov, MD, MPH, MS^8*, Eunice Chang, PhD^8*, Michael S. Broder, MD, MSHS^8* and Preeti Bajaj, PhD^9*

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
³Section of Hematology and Medical Oncology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
⁴Atrium Health Levin Cancer Institute, Charlotte, NC
⁵Karmanos Cancer Institute, Detroit, MI
⁶Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA
⁷Levine Cancer, Atrium Health, Charlotte, NC
⁸PHAR (Partnership for Health Analytic Research), Beverly Hills, CA
⁹Prothena Biosciences, Inc., South San Francisco, CA

Mahek Garg, PhD¹, Ambika Satija, PhD^2*, Yan Song, PhD^2*, Ben Meade, BA^3*, James Signorovitch, PhD^2* and Shravanthi Gandra, PhD, MBA^4*

¹Merck Sharp & Dohme LLC, Rahway, NJ
²Analysis Group, Inc., Boston, MA
³Analysis Group, Inc, Paris, France
⁴Merck & Co., Inc., Rahway, NJ

Chloé Herledan, PhD, PharmD^1,2*, Florence Ranchon, PharmD, PhD^2,3*, Marie Preau, PhD^4*, Agathe Komaroff^5*, Anissa Guillemin, PhD^2,5*, Magali Maire, PhD^6*, Anne-Gaëlle Ruiz-Caffin, PharmD^7*, Lionel Karlin^8*, Emmanuelle Ferrant^9*, Gilles Salles, MD, PhD¹⁰, Hervé Ghesquieres, MD, PhD^11* and Catherine Rioufol, PharmD, PhD^3*

¹Pharmacy Department, Lyon Sud University Hospital, Pierre-Benite, CZ, France
²EA 3738 CICLY, Lyon 1 University, Oullins, France
³Pharmacy Department, Lyon Sud University Hospital, Pierre-Benite, France
⁴UMR 1296 Radiations : Défense, Santé, Environnement, Lyon 2 University, Lyon, France
⁵Lyon Sud University Hospital, Pierre-Bénite, France
⁶Hematology Department, Lyon Sud University Hospital, Pierre-Benite, France
⁷Lyon Sud University Hospital, Pierre-Benite, France
⁸Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre-Bénite, France
⁹Department of Hematology, Lyon Sud Hospital, Pierre Benite, France
¹⁰Lymphoma Service Chief, Memorial Sloan Kettering Cancer Center, New York, NY
¹¹Department of Hematology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France

Maria Florencia Comelles, MD^1*, Alexandra Grudzinski^2* and Lisa K Hicks, MD^3,4,5

¹St. Michael's Hospital, University of Toronto, Toronto, ON, Canada
²Division of Hematology/Oncology, St. Michael’s Hospital, Toronto, ON, Canada
³Li Ka Shing Knowledge Institute, University of Toronto, Toronto, ON, Canada
⁴Division of Hematology/Oncology, St. Michael's Hospital, Toronto, ON, Canada
⁵Department of Medicine, University of Toronto, Toronto, ON, Canada